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Despite the availability of vaccines for Japanese encephalitis virus (JEV), the re-
emerging virus remains a clinically important pathogen that causes acute encephalitis
and permanent neuropsychiatric sequels. JEV highly targets dopaminergic neuron-
rich brain regions including the thalamus and midbrain. The molecular mechanism
contributing to the high susceptibility of these particular brain regions remains largely
unclear. This study addressed whether this tissue tropism of JEV is associated with
signaling of dopaminergic neurons. Three pieces of evidence indicate that JEV exploits
dopamine signaling to facilitate its infection: (1) JEV infection modulates dopamine level;
(2) a selective dopamine D2 receptor (D2R) agonist enhances JEV infection; and (3)
stimulation of D2R activates phospholipase C (PLC) to enhance the surface expression
of JEV binding/entry molecules, integrin β3 and vimentin. Overall, JEV may exploit
dopamine-mediated neuronal communication to increase the susceptibility of D2R-
expressing cells to JEV infection. This study identifies a potential underlying mechanism
of viral invasiveness in the dopaminergic brain regions and suggests antiviral strategies
against viral infection by targeting D2R-PLC signaling.
Keywords: Japanese encephalitis virus, dopaminergic neuron, dopamine D2 receptor, phospholipase C, viral
binding/entry molecule
INTRODUCTION
Japanese encephalitis virus (JEV), transmitted by mosquitoes, is the most clinically important
etiological agent of viral encephalitis, with an estimated worldwide annual incidence of 30,000 to
50,000 cases. About 25–30% of these cases are fatal and 50% result in permanent neuropsychiatric
sequel including impaired cognition, poliomyelitis-like paralysis and Parkinsonian movement
disorders (Mackenzie et al., 2004). JEV, a flavivirus with positive-sense RNA genome, enters
cell by receptor mediated endocytosis and the acidic pH of endosome causes conformational
changes in envelope protein leading to release of genome into cytoplasm. Translation of viral
RNA produces proteins required for viral RNA replication through RNA-dependent RNA
polymerization along with host factors. Virus assembly is taken place within the endoplasmic
reticulum-derived membrane compartments and non-infectious particles traverse through Golgi
complex where furin-mediated cleavage of prM leads to conformational changes producing the
infectious virion, which are then released into extracellular compartment through cellular secretory
pathway. JEV invades the central nervous system (CNS) and primarily infects neuronal cells
(Unni et al., 2011). In CNS infection, the thalamus and midbrain are the most severely affected
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(Kalita and Misra, 2000). Moreover, JEV RNA copy number is
abundant in these brain areas as compared to other regions
(Srivastava et al., 2013). However, we lack an understanding of
the high susceptibility of these brain areas to JEV.
The midbrain is rich in number of dopaminergic neurons
as the major source of dopamine in the mammalian CNS
(Chinta and Andersen, 2005). In addition, the thalamus has been
reported to be a key target for brain dopamine that also displays
dopaminergic phenotypes (Sanchez-Gonzalez et al., 2005).
Dopamine is the main catecholamine neurotransmitter that
controls a wide variety of biological functions including voluntary
movement, cognition, and endocrine regulation (Missale et al.,
1998). Dopamine biosynthesis is regulated by phosphorylation
of tyrosine hydroxylase (TH), the rate-limiting enzyme that
hydrolyses tyrosine to L-DOPA (Daubner et al., 2011). The
effects of dopamine are mediated by dopamine receptors (DRs),
members of the G protein-coupled receptor (GPCR) superfamily.
There are two types of DR: dopamine D1-like receptors including
D1R and D5R subtypes and dopamine D2-like receptors
including D2R, D3R, and D4R subtypes (Missale et al., 1998).
Dopamine has greater binding affinity for D2- than D1-like
receptors (Marcellino et al., 2012).
Signal transduction of DRs on agonist binding involves
canonical cyclic adenosine monophosphate (cAMP) pathway.
To produce cAMP from adenosine triphosphate (ATP),
D1-like receptors activate adenylyl cyclase (AC) by inducing
heterotrimeric G proteins Gαs and Gαolf. On the other
hand, through Gαi and Gαo, D2-like receptors may inhibit the
activation of AC (Beaulieu and Gainetdinov, 2011). Alternatively,
D2R subtype and D2R-D1R heterodimer via Gαq and Gβγ can
stimulate the release of intracellular calcium stores by activating
inositol triphosphate receptor (IP3R) via inositol triphosphate
(IP3), the product of phospholipase C (PLC) hydrolysis
(Hernandez-Lopez et al., 2000; Yang et al., 2003; Lee et al., 2004).
Dopamine receptors are involved in virus infections.
Dopamine can enhance HIV infection by up-regulating the
surface HIV entry co-receptor in human macrophages and
DR antagonists can inhibit this enhancement (Gaskill et al.,
2014). Prochlorperazine, a D2R antagonist, can block Dengue
virus (DENV) infection and protect mice against lethal DENV
infection (Simanjuntak et al., 2015; Lai et al., 2017). Moreover,
prochlorperazine also has an antiviral effect against JEV
infection. However, whether JEV exploits dopaminergic signal
transduction for viral replication is unknown. Here, we aimed to
examine the interplay between JEV and dopaminergic neuronal
cells and the underlying mechanism.
MATERIALS AND METHODS
Viruses, Cell Lines, and Chemicals
The neurovirulent RP-9 strain of JEV was used for both in vitro
and in vivo studies and was propagated in mosquito C6/36
cells as described (Chen et al., 1996). Viruses were titrated
by plaque-forming assay in baby hamster kidney BHK-21
cells (ATCC: CCL-10). Dopaminergic human neuroblastoma
BE(2)C cells (ATCC CRL-2268) were cultured in RPMI 1640
medium (Gibco) supplemented with 10% fetal bovine serum.
Primary antibodies included anti-JEV-NS3, anti-phospho-
tyrosine hydroxylase (Cell Signaling, #2791), anti-tyrosine
hydroxylase (Cell Signaling, #2792), anti-D2R (Santa Cruz
Biotechnology, sc-9113), anti-D1R (Santa Cruz Biotechnology,
sc-1434), anti-phospho-CaMKII (Thermo Scientific, 22B1),
anti-integrin β3 (BD Biosciences, 611140), anti-vimentin
(Sigma, V6389), anti-β-actin (Chemicon), and anti-α-tubulin
(Sigma–Aldrich).
Mouse Study
Mouse experiments were approved and performed in accordance
with the guidelines of the Academia Sinica Institutional Animal
Care and Use Committee. Groups of 4-week-old AG129 mice
were used to evaluate the effect of D2R agonist and antagonists
on animal survival. Mice were challenged intraperitoneally with
5 × 104 PFU/mouse of JEV and simultaneously injected with
30 µl PBS intracranially into the right hemisphere of the brain.
Immediately, mice received PBS (vehicle control, n = 5) or 8 mg
QH (D2R agonist)/kg body weight intravenously in the absence
(QH, n = 5) or presence of either 8 mg D1R antagonist/kg body
weight (QH+SCH23390, n = 5) or 8 mg D2R antagonist/kg
body weight (QH+Haloperidol, n = 5). The animal survival was
monitored daily.
Virus Infection
Cells were adsorbed with JEV [multiplicity of infection (MOI),
1 or 5] for 2 h. Cells were washed to remove unbound virus
and incubated for the indicated times. For antiviral assays, cells
were adsorbed with JEV (MOI, 0.1) with the indicated doses of
chemical compounds for 2 h, washed thoroughly, then incubated
for 24 h with and without chemical compounds.
Lentivirus Preparation and
D2R-Knockdown
The lentivirus vector pLKO.1, which carries a short hairpin
RNA (shRNA) targeting the human D2R (5′-GTCCTGG
GAGACCCATGTAAA-3′, TRCN0000315421) or LacZ (5′-TGT
TCGCATTATCCGAACCAT-3′, TRCN0000072223), obtained
from the Taiwan National RNAi Core Facility, was cotransfected
with pMD.G and pCMV1R8.91 into HEK293T cells by use
of Lipofectamine 2000 (Invitrogen). The lentiviruses were
harvested from culture supernatants and concentrated by
ultracentrifugation at 35,000 rpm in a Beckman SW41 rotor for
3.5 h at 4◦C. The viral pellets were re-suspended and used to
transduce BE(2)C cells. The D2R-deficient BE(2)C cells (shD2R-
BE(2)C) and LacZ-control cells (shLacZ-BE(2)C) were selected
with puromycin (10 µg/ml).
Dopamine Assay
Quantitative assay of dopamine was performed according to
the manufacturer’s protocol (Dopamine ELISA kit, KA3838-
Abnova). Briefly, 250 µl of cell culture medium was used for
enzymatic conversion. Sample absorbance was determined by use
of an ELISA reader (Molecular Devices) at 450 nm.
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cAMP, Myo-inositol 1 Phosphate (IP1),
and Calcium Measurements
cAMP level in cell lysate (10 µg) was measured by
chemiluminescent enzyme-linked immunosorbent assay kit (Cell
Biolabs). Quantitative assay of IP1 was performed according
to the manufacturer’s protocol (IP-One Tb Cisbio Bioassays).
Briefly, cells were plated in a 96-well black clear-bottom plate
(50,000 cells/well) overnight. The level of IP1 in cell lysate
was measured by use of SpectraMax M5 (Molecular Devices;
Fluorescence ratio: 668/620 nm). Changes in intracellular
cytosolic calcium level were evaluated by using calcium-sensitive
dye Fluo-4AM (Calcium assay kit, Molecular Probes) with a
fluorescence microplate reader (Spectramax, Molecular Devices).
Cells were loaded with Fluo-4AM dye in HEPES-buffered
Modified Hanks’ Balanced Salt Solution without phenol red and
calcium. Cells were incubated for 10 min at 37◦C. Quinpirole
hydrochloride (QH) at the indicated doses was added to cells
and fluorescence intensity was recorded at 5 min intervals over
30 min at room temperature.
Preparation of Fluorescently
Labeled JEV
Japanese encephalitis virus was purified and labeled with
Lightning-Link Atto-488 (Innova Biosciences) as described
(Liang et al., 2011). Briefly, virus was ultracentrifuged through
a 35% sucrose cushion at 35,000 rpm in a Beckman SW41 rotor
for 3.5 h at 4◦C. The viral pellets were re-suspended in PBS and
labeled with Lightning-Link Atto-488 (Innova Biosciences).
Virus Binding/Entry Assays
Cells were adsorbed with JEV for 2 h with rocking on a linear
shaker at room temperature for virus binding/entry assay. The
cells were washed three times with cold PBS. Virus binding/entry
was evaluated by confocal microscopy with fluorescently labeled
(MOI, 20∼30) and plaque-forming assay with unlabeled JEV
(MOI, 5). For virus binding assay, cells were adsorbed with JEV
for 1 h at 4◦C with rocking on linear shaker. For the virus entry
assay, cells were adsorbed with JEV for 1 h at 4◦C. After a gentle
wash with cold medium, cells were shifted to 37◦C incubator
for 1 h to allow virus entry. Cells were then treated with acid
glycine (0.1 M, pH = 3) to inactivate non-internalized virus for
5 min and washed with cold HBSS. Cells were harvested with
use of cell scrapers, and the adsorbed viruses were released by
passing the cells through a 27-G needle 3 times. Cell lysates were
centrifuged at 12,000 rpm for 1 min, and the supernatant was
used for plaque-forming assay.
Flow Cytometry
Cells were plated in a 6-well plate for overnight. After
treatments, cells were immunostained with anti-integrin β3 (BD
Biosciences, 611140) or anti-vimentin (Sigma, V6389) without
cell permeabilization for 1 h, then washed thoroughly and
incubated with Alexa Fluor-488-conjugated secondary antibody
(Molecular Probes) for 1 h at room temperature. After washing,
cells were harvested with use of cell scrapers and passed through
cell strainer. FACSCanto flow cytometry was used to measure
signal intensity of respective proteins.
Statistical Analysis
Data are presented as mean ± standard deviation (SD).
For comparison of three or more categorical data, ANOVA-
Bonferroni post hoc test was used. Two categorical data were
compared by independent Student t-test. The statistical tests were
two-tailed and significance was set at P < 0.05 and < 0.01.
For immunoblotting, the band density was quantified by use
of ImageJ (US National Institutes of Health). A survival curve
was descriptively analyzed by use of SigmaPlot v10.0 (Systat
Software). Determination of the median survival time (T50)
and P-values, by the log-rank test, involved used of Prism v5.0
(GraphPad Software).
RESULTS
JEV Modulates Dopamine Levels
To investigate whether JEV affects dopamine production, we
used dopaminergic human neuroblastoma BE(2)C cells, which
show a high level of TH activity for dopamine synthesis (Kim
et al., 1996). JEV-infected BE(2)C cells released a significantly
higher level of dopamine at 3 and 6 h post-infection (hpi) as
compared with mock-infected cells; however, at later times of
24 and 36 hpi dopamine release was reduced by JEV infection
(Figure 1A), probably due to cytopathic effect caused by JEV.
Consistently, JEV also modulated the rate-limiting enzyme of
dopamine biosynthesis, with an increase of phospho-TH levels
at 3 and 6 hpi and decrease at later times, when JEV-NS3 was
abundant (Figure 1B). Notably, UV-inactivated JEV (UV-JEV)
also significantly increased dopamine and phospho-TH levels at
3 and 6 hpi but different from that of JEV, the levels were not
decreased by UV-JEV at 24 and 36 hpi (Figures 1A,B). These data
suggest that JEV increases dopamine levels at the early stage of
infection probably through viral binding/entry.
D2R Antagonists Suppress JEV Infection
The biological effect of dopamine is mediated by DRs and to
elucidate their role in JEV infection, we used selective antagonists
targeting dopamine D1- or D2-like receptors (Missale et al.,
1998). Similar to our previous study with D2R antagonist
prochlorperazine (Simanjuntak et al., 2015), the D2R antagonists
haloperidol and risperidone dose-dependently reduced JEV-NS3
protein expression and viral progeny production as compared
with solvent-treated cells (Figures 1C,D). SCH23390, a D1R
antagonist, also inhibited JEV infection, although it required a
relatively high dose (Figures 1C,D). Thus, our data indicate the
major role of D2R in JEV infection as compared with D1R.
Stimulation of D2R Enhances JEV
Infection
To address the role of D2R activation in JEV infection, we
used a D2R-specific agonist with putative dopaminergic
properties, QH (Koller et al., 1987). Treatment of QH for 2 h
Frontiers in Microbiology | www.frontiersin.org 3 April 2017 | Volume 8 | Article 651
fmicb-08-00651 April 7, 2017 Time: 17:21 # 4
Simanjuntak et al. JEV Infection in Dopaminergic Neuron
FIGURE 1 | Japanese encephalitis virus (JEV) modulates dopamine levels and D2R antagonists suppress JEV infection. (A,B) Human BE(2)C cells were
infected with JEV or UV-inactivated JEV for 3, 6, 24, and 36 h. ELISA of dopamine level in the culture supernatant (A); and western blot analysis of protein levels of
phospho-TH, total TH, JEV-NS3 and actin in cell lysates (B) at the indicated time [hours post-infection (hpi)]. Western blot analysis; relative ratio of phospho-TH to
TH or NS3 to actin. (C,D) BE(2)C cells were infected with JEV with and without D2R antagonists [haloperidol (HALO) and risperidone (RISP)] or D1R antagonist
SCH23390 (SCH) for 24 h. Western blot analysis of JEV-NS3 and actin; relative percentage of NS3 to actin was adjusted to solvent control (C). Plaque-forming
assay of viral progeny production in culture supernatant (D). Data are mean ± SD (n = 3). ∗P < 0.05, ∗∗P < 0.01.
before JEV infection dose-dependently enhanced JEV-NS3
expression and viral progeny production (Figures 2A–C).
To verify the requirement of D2R in QH-enhanced JEV
infection, we knocked down D2R expression in BE(2)C
cells by transduction with a lentivirus expressing shRNA
targeting human D2R (shD2R). The knockdown of D2R
did not affect D1R expression and cellular localization
(Figure 2D). The enhancement effect of QH on JEV-NS3
expression and viral progeny production was significantly
lower in shD2R-BE(2)C cells than parental BE(2)C cells and
knockdown control shLacZ-BE(2)C cells (Figures 2E–G). To
further confirm the biological significance of D2R activation
on JEV infection, we performed animal challenge experiment.
QH treatment significantly accelerated animal mortality as
compared with PBS treatment in JEV-challenged AG129
mice (T50: 4 days vs. 8 days) (Figure 2H). Notably, this
acceleration of animal mortality was abolished in the presence
of D2R antagonist (haloperidol; T50 = 9 days) but not D1R
antagonist (SCH23390; T50 = 4 days) (Figure 2H). These data
demonstrate that stimulation of D2R positively regulates JEV
infection.
JEV Infection and D2R Stimulation
Activate Phospholipase C (PLC)
Signaling Cascade
To determine the D2R signaling event involved in JEV life
cycle, we evaluated the major pathways of AC and PLC
downstream of D2R stimulation (Figure 3A). Through Gαi/αo,
D2R may inhibit AC to negatively regulate cAMP level (Beaulieu
and Gainetdinov, 2011), while via Gαq/βγ D2R may activate
PLC to hydrolyzes phosphatidylinositol 4,5-biphosphate (PIP2)
to inositol 1,4,5-triphosphate (IP3). IP3 then stimulates the
release of calcium from intracellular stores before it is rapidly
degraded to IP2 and then IP1 (Trinquet et al., 2006). At
the early time of JEV infection when dopamine level was
elevated (3∼6 h), cAMP levels were similar between mock
and JEV-infected BE(2)C cells (Figure 3B). However, the
levels of IP1 were significantly increased by JEV infection
(Figure 3C). Furthermore, treatments with PLC signaling
inhibitors at non-cytotoxic doses and in the range of their IC50
(Supplementary Figure S1) dose-dependently reduced JEV-NS3
expression and viral progeny production (Figure 3D). Thus, PLC
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FIGURE 2 | Stimulation of D2R enhances JEV infection. (A–C) BE(2)C cells were treated with the D2R-specific agonist quinpirole hydrochloride (QH) for 2 h,
then infected with JEV for 24 h. Immunofluorescence microscopy (200× original magnification) of cells immunostained for JEV-NS3 (green) and Hoechst for nuclei
(blue) (A). Western blot analysis of JEV-NS3 and actin; relative percentage of NS3 to actin were adjusted to solvent control (B). Plaque-forming assay of viral progeny
production in culture supernatant (C). (D) Knockdown efficiency of D2R expression in BE(2)C. Confocal microscopy (400× original magnification) of cells
immunostained for D2R (red), D1R (green) and Hoechst for cell nuclei (blue). (E–G) Cells including BE(2)C, shD2R-BE(2)C, and shLacZ-BE(2)C were treated with QH
for 2 h were infected with JEV for 24 h. Immunofluorescence microscopy (200× original magnification) of cells immunostained for JEV-NS3 (green) and Hoechst for
nuclei (blue) (E). Western blot analysis of JEV-NS3 and actin; relative percentage of NS3 to actin were adjusted to BE(2)C (F). Plaque-forming assay of viral progeny
production in culture supernatant (G). Data are mean ± SD (n = 3). ∗P < 0.05, ∗∗P < 0.01. (H) AG129 mice were challenged with JEV and immediately received
phosphate-buffered saline (PBS; n = 5) or 8 mg QH/kg body weight intravenously in the absence (QH, n = 5) or presence of either 8 mg D1R antagonist/kg body
weight (QH+SCH23390, n = 5) or 8 mg D2R antagonist/kg body weight (QH+Haloperidol, n = 5). Mice survival was presented as percentage of survival. The median
survival time (T50) and P-value, by the log-rank test, are presented. ∗∗P < 0.01, compared with QH-treated group.
signaling pathway is involved in JEV infection in dopaminergic
BE(2)C cells.
Next, we verified the activation of PLC pathway by
the D2R agonist QH. Treatment with QH dose-dependently
increased IP1 production as compared with solvent treatment
(Figure 3E). This QH-induced IP1 production was associated
with D2R because IP1 level was lower in shD2R-BE(2)C
than BE(2)C cells and knockdown control shLacZ-BE(2)C
cells. Similarly, JEV infection induced IP1 production in a
D2R-associated mechanism, since lower IP1 level was noted
in cells with D2R knockdown (Figure 3E). In addition, QH
dose-dependently increased cytosolic calcium level as measured
by Fluo-4 AM calcium indicator assay (Figure 3F). Notably,
cytosolic calcium level was lower in shD2R-BE(2)C than
control cells with QH treatment, so QH-mediated calcium
flux was associated with D2R. This D2R-dependent effect on
cytosolic calcium level was also observed in JEV-infected cells
(Figure 3F).
Calcium flux may activate calcium-dependent enzymes such
as CaMKII, the most abundant neuronal protein kinase in the
brain (Berridge et al., 2003; Okamoto et al., 2009). Calcium
flux and CaMKII activation triggered by DR-mediated signaling
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FIGURE 3 | Japanese encephalitis virus infection and D2R stimulation activate phospholipase C (PLC) signaling cascade. (A) Major D2R signaling
molecules (black) and the signaling inhibitors (red). (B,C) BE(2)C cells were infected with JEV for 3 and 6 h. Chemiluminescent ELISA of cAMP levels in the cell
lysates (B). IP1 levels in cell lysates were determined by homogeneous time-resolved fluorescence (C). (D) BE(2)C cells were infected with JEV with and without PLC
signaling cascade inhibitors at the indicated concentrations for 24 h. Western blot of JEV-NS3 and actin; relative percentage of JEV-NS3 to actin were adjusted to
solvent control (upper panel). Plaque-forming assay of viral progeny production in culture supernatant (lower panel). (E) Cells including BE(2)C (gray), shD2R-BE(2)C
(white), and shLacZ-BE(2)C (striped) were treated with D2R-specific agonist QH for 2 h at the indicated doses or infected with JEV for 3 h. IP1 levels in cell lysates
were determined by homogeneous time-resolved fluorescence. (F) Cells were treated with QH for 30 min at the indicated doses or infected with JEV for 1 h, then the
highest peak of Fluo-4 AM in the cells was determined by fluorescence microplate reader. (G) BE(2)C cells were treated with QH or infected with JEV for 5 h. Cells
were immunostained for pCaMKII (green) and Hoechst for nuclei (blue). Confocal microscopy images are shown (400× original magnification, upper panel). Cells
were stained with Alexa Fluor 568 phalloidin for F-actin (red) and Hoechst for nuclei (blue). Confocal microscopy images are shown (630× original magnification,
lower panel). Data are mean ± SD (n = 3). ∗P < 0.05, ∗∗P < 0.01.
can affect cell morphology by regulating cytoskeletal dynamics
(Rosenberg and Spitzer, 2011). Treatment with QH and JEV
infection for 5 h greatly increased phosphorylated CaMKII T286
(pCaMKII) level, a marker of CaMKII activation (Coultrap and
Bayer, 2012), and also altered the cell shape to form neurite-like
structures with high actin composition (Figure 3G). Together,
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FIGURE 4 | D2R-mediated PLC signaling enhances JEV binding/entry. (A,B) BE(2)C cells were treated with QH with and without PLC signaling inhibitors for
5 hr, then infected with fluorescently labeled JEV (A, green) or unlabeled JEV (B) for 2 h at room temperature with rocking on a linear shaker. Confocal microscopy
(630× original magnification) of cells stained with Alexa Fluor 568 phalloidin for F-actin (red) and Hoechst for nuclei (blue) (A). The level of virus binding/entry was
quantified by plaque-forming assay (B). (C) Cells were treated with QH with or without PLC signaling inhibitors for 5 h, then JEV binding was performed at 4◦C for
1 h. The level of virus binding was quantified by plaque-forming assay. (D) Cells were treated with QH with or without PLC signaling inhibitors for 5 h, then cells were
adsorbed with JEV at 4◦C for 1 h. After washing with medium, cells were incubated at 37◦C for an additional hour. The level of virus entry was quantified by
plaque-forming assay. (E–G) BE(2)C cells were adsorbed with JEV for 2 h, then treated with QH (20 µM) for 2 or 5 h, replenished with QH-free medium, and
incubated for 24 h. Western blot analysis of JEV-NS3 and actin; relative percentage of NS3 to tubulin were adjusted to solvent control (E); plaque-forming assay of
viral progeny production in culture supernatant (F); and level of intracellular JEV RNA (G). Data are mean ± SD (n = 3). ∗P < 0.05, ∗∗P < 0.01.
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these data demonstrate that D2R stimulation and JEV infection
induces a PLC signaling cascade in BE(2)C cells.
D2R-Mediated PLC Signaling Enhances
JEV Binding/Entry
To dissect the viral life cycle affected by D2R-PLC activation,
we performed viral binding/entry study in BE(2)C cells with
or without QH pretreatment for 5 h. The amount of JEV
binding/entry was significantly increased with QH treatment
(Figures 4A,B). Furthermore, this enhancement in QH-treated
cells was concomitantly reduced with PLC signaling cascade
inhibitors KN93, 2APB, and U73122 (Figures 4A,B). To
further address the effect on viral binding and/or viral
entry, we performed virus binding and virus entry assays
as described in the section “Materials and Methods.” Both
JEV binding and entry were significantly increased by
QH treatment and this enhancement could be repressed
by PLC signaling inhibitors and with D2R knockdown in
shD2R-BE(2)C cells (Figures 4C,D). However, D2R stimulation
had no effect on post-entry step of JEV infection because
treatments with QH after virus adsorption did not significantly
change JEV-NS3 expression, virus progeny production, and
intracellular JEV RNA level (Figures 4E–G). Therefore,
D2R-mediated PLC signaling plays a role in enhancing JEV
binding/entry.
D2R-PLC Activation Increases the
Surface Expression of JEV Binding/Entry
Molecules
Phospholipase C activation increases cytosolic calcium level,
which in turn activates calcium-dependent kinases and/or
directly enhances actin assembly to facilitate the formation
of focal adhesion on the cell surface (Prevarskaya et al.,
2011). One of the main components of focal adhesion, αvβ3
integrin adhesion receptor, has been reported to mediate entry
of flavivirus such as West Nile virus and JEV (Chu and
Ng, 2004). Furthermore, integrin β3 is involved in recruiting
vimentin to the cell surface (Bhattacharya et al., 2008) and
our previous work indicated the role of vimentin in JEV
binding and virulence (Liang et al., 2011). Thus, we tested
whether the surface expression of integrin β3 and vimentin was
increased with treatment of the D2R agonist, QH. Treatment
with QH for 5 h greatly increased the surface expression of
integrin β3 and vimentin as compared to solvent-treatment
in BE(2)C cells (Figures 5A,B) dependent on PLC because
the PLC inhibitor U73122 reversed this effect (Figure 5B).
The increased surface expression of integrin β3 and vimentin
was not likely due to the effect on protein expression
because their total protein levels were not changed by QH
(Figure 5C).
To support the role of integrin β3 and vimentin in D2R-PLC-
enhanced JEV binding/entry, we performed antibody-blockage
experiments. BE(2)C cells-treated with QH for 5 h underwent
viral binding/entry assay with and without antibodies against
integrin β3 and vimentin. The enhanced JEV binding/entry
with QH was significantly repressed by anti-integrin β3 and
anti-vimentin antibodies as compared with mouse IgG control
(Figures 5D,E). These data suggest that D2R-PLC-enhanced JEV
binding/entry is associated with the increased surface expression
of JEV binding/entry molecules including integrin β3 and
vimentin.
DISCUSSION
Japanese encephalitis virus infection of the brain mostly
targets dopaminergic neuron-rich areas, the thalamus and
midbrain (Kalita and Misra, 2000; Chinta and Andersen,
2005; Sanchez-Gonzalez et al., 2005; Srivastava et al., 2013).
Here, we provide evidence to explain this tissue tropism by
revealing an interesting approach adapted by JEV to exploit
the dopaminergic system to enhance its viral life cycle. The
dopamine production is significantly increased at the early stage
of JEV infection. The increased level of dopamine may be
implicated in the susceptibility of neighboring cells to JEV via
D2R-PLC-associated signal transduction. Stimulation of D2R
by dopamine activates PLC signaling cascade. PLC hydrolyzes
phosphatidylinositol 4,5-biphosphate (PIP2) to inositol 1,4,5-
triphosphate (IP3) (Trinquet et al., 2006). IP3 then stimulates
the release of calcium from intracellular stores which in turn
activate calcium-dependent enzymes such as CaMKII, the most
abundant neuronal protein kinase in the brain (Berridge et al.,
2003; Okamoto et al., 2009). CaMKII activates focal adhesion
kinase to mediate formation of surface focal adhesion including
αvβ3 integrin that plays a role in JEV entry (Chu and Ng,
2004; Prevarskaya et al., 2011). Furthermore, integrin β3 is
involved in the cell surface recruitment of vimentin, a binding
molecule of JEV in neuronal cells (Bhattacharya et al., 2008;
Liang et al., 2011). Thus, D2R-PLC activation may increase
JEV binding/entry to enhance JEV infection (as outlined in
Figure 6).
Our data indicate that JEV can induce hyperdopaminergia
during the early stage of infection. Presumably, elevated
dopamine level above the basal level may confer favorable
conditions for viral life cycle, because hyperdopaminergia may
alter cellular responses such as protein kinase C-mediated
ERK and Akt expression (Beaulieu and Gainetdinov, 2011).
Involvement of hyperdopaminergia is implied in HIV infection.
Methamphetamine, a psychostimulant that increases the level
of extracellular dopamine, enhances HIV infection in human
macrophages (Liang et al., 2008; Taylor et al., 2013). Moreover,
treatment with dopamine significantly increases HIV entry by
enhancing the surface expression of CCR5 via DR-PLC activation
(Gaskill et al., 2014). Several meningoencephalitis viruses have
been reported to activate PLC. For example, M33, a GPCR
encoded by murine cytomegalovirus, can trigger protein kinase C
signaling via Gq protein-coupled PLC activation to support viral
replication and take a part in pathogenesis (Sherrill et al., 2009).
Group B coxsackieviruses, a leading cause of aseptic meningitis,
can induce PLC-dependent intracellular calcium release to
activate a cysteine protease for entering brain endothelial cells
(Bozym et al., 2010). In addition, PLC signaling plays a role
in the entry of influenza A virus H1N1 but not H3N2, via an
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FIGURE 5 | D2R-PLC activation increases the surface expression of JEV binding/entry molecules. BE(2)C cells were treated with or without D2R-specific
agonist QH at the indicated concentration for 5 h. (A,B) Without permeabilization, cells were immunostained for integrin β3 [green, (A, left 2 panels)] or vimentin
[green, (A, right 2 panels)]. Cells were also stained with Alexa Fluor 568 phalloidin for F-actin (red) and Hoechst for nuclei (blue). Confocal microscopy images (630×
original magnification). Histogram [mean fluorescence intensity (MFI)] of surface integrin β3 (B, left panel) or vimentin (B, right panel) of QH-treated cells with or
without specific PLC inhibitor (U73122, 5 µM) was measured by flow cytometry. (C) Western blot analysis of integrin β3, vimentin and actin; relative percentage of
integrin β3 or vimentin to actin were adjusted to solvent control. (D,E) BE(2)C cells were infected with unlabeled JEV (D) or fluorescently labeled JEV (E, green) for 2 h
at room temperature with or without anti-integrin β3 and anti-vimentin antibody (0.75 and 1.5 µg/ ml). Mouse immunoglobulin G (IgG) was used as antibody control
(1.5 µg/ml). The level of virus binding/entry was quantified by plaque-forming assay (D). Cells with or without antibody (1.5 µg/ ml) were stained with Alexa Fluor 568
phalloidin for F-actin (red) and Hoechst for nuclei (blue). Confocal microscopy images (630× original magnification) (E). Data are mean ± SD (n = 3). ∗∗P < 0.01.
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FIGURE 6 | Japanese encephalitis virus infection in dopaminergic neurons. JEV infects dopaminergic neurons and upregulates dopamine production and
release at the early stage of infection. This in turn may activate D2R-PLC signaling pathway of the surrounding D2R-expressing cells. Activation of D2R-PLC
increases surface expression of the molecules involved in JEV binding/entry and then enhances JEV infection.
unclear mechanism (Zhu et al., 2014). Interestingly, genome
wide association studies (GWAS) of dengue patients revealed
a single nucleotide polymorphism (SNP) in the gene PLC,
epsilon 1, associated with severe dengue shock syndrome (Khor
et al., 2011; Dang et al., 2014). Here, we add JEV to the
list of viruses whose life cycle interacts with the D2R-PLC
pathway.
Emerging and clinically important flaviviruses have ability
to enter the CNS and infect neuronal cells (Sips et al., 2012).
For instance, West Nile virus and dengue virus infections cause
pathological features in the thalamus, another main source
of brain dopamine (Solomon, 2004; Sanchez-Gonzalez et al.,
2005; Malik et al., 2014). Zika virus (ZIKV), a recent public
health problem, has been linked to neonatal microcephaly in
that ZIKV can target developing brain cells (Garcez et al.,
2016). Interestingly, dopamine and D2R may play a critical
role in the developing human brain (Rothmond et al., 2012).
Whether dopamine-related signaling may also take part in
the life cycle and pathogenesis of these flaviviruses remains
elusive.
Overall, our results revealed elevated dopamine level at
the early stage of JEV infection to enhance viral entry in
D2R-expressing cells via a PLC-mediated signaling pathway. Our
study proposes a possible explanation for the high susceptibility
of dopaminergic brain regions to viral pathogenesis and suggests
a therapeutic strategy against viral infection by targeting
D2R-PLC signal transduction.
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